Extreme deep white matter hyperintensity volumes are associated with African American race

Cerebrovascular Diseases

Volumn 37, Issue 4, 2014, Pages 244-250

  Nyquist, Paul A ^a   Bilgel, Murat S ^a   Gottesman, Rebecca ^a   Yanek, Lisa R ^a   Moy, Taryn F ^a   Becker, Lewis C ^a,b   Cuzzocreo, Jennifer ^a,b   Prince, Jerry ^a,b   Yousem, David M ^b   Becker, Diane M ^a   Kral, Brian G ^a,b   Vaidya, Dhananjay ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Coronary artery disease; Imaging; Risk factors; White matter disease; Women and minorities

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRAIN DAMAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR HEALTH STUDY SCORE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DEEP WHITE MATTER HYPERINTENSITY VOLUME; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIRST DEGREE RELATIVE; HUMAN; HYPERTENSION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PERIVENTRICULAR VOLUME; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SMOKING; VASCULAR DISEASE; WHITE MATTER; WHITE MATTER LESION; AGE; CAUCASIAN; CEREBROVASCULAR DISORDERS; MIDDLE AGED; PATHOLOGY; PROCEDURES; BODY COMPOSITION; CONTROLLED STUDY; EUROPEAN AMERICAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; SENESCENCE; SEX DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; WHITE MATTER;

EID: 84897117651     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000358117     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; American Heart Association Statistics Committee, Stroke Statistics Subcommittee: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-486.
2. Gorelick PB: Cerebrovascular disease in African Americans. Stroke 1998; 29: 2656-2664.
3. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL: Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005; 111: 1327-1331.
4. Young VG, Halliday GM, Kril JJ: Neuropathologic correlates of white matter hyperintensities. Neurology 2008; 71: 804-811.
5. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126-1129.
6. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN: Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994; 25: 318-327.
7. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G: The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16: 149-162.
8. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20.
9. Raz N, Yang Y, Dahle CL, Land S: Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta 2012; 1822: 361-369.
10. Wen W, Sachdev P: The topography of white matter hyperintensities on brain MRI in healthy 60-to 64-year-old individuals. Neuroimage 2004; 22: 144-154.
11. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL: Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology 2008; 70: 425-430.
12. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton SB, Shaw PJ, O'Brien JT, Ince PG: White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006; 37: 1391-1398.
13. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, Manduca A, Avula R, Erickson BJ: FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001; 14: 668-676.
14. Ramirez J, Gibson E, Quddus A, Lobaugh NJ, Feinstein A, Levine B, Scott CJ, Levy-Cooperman N, Gao FQ, Black SE: Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage 2011; 54: 963-973.
15. Van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, van Es AC, Palm WM, Spilt A, Bollen EL, Blauw GJ, Launer L, Westendorp RG, van Buchem MA; PROSPER Study Group: Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. AJNR Am J Neuroradiol 2006; 27: 875-878.
16. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ: A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003; 290: 1049-1056.
17. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68: 899-917.
18. Myers GL, Kimberly MM, Waymack PP, Smith SJ, Cooper GR, Sampson EJ: A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000; 46: 1762-1772.
19. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ: White matter lesions impair frontal lobe function regardless of their location. Neurology 2004; 63: 246-253.
20. Bazin PL, Cuzzocreo JL, Yassa MA, Gandler W, McAuliffe MJ, Bassett SS, Pham DL: Volumetric neuroimage analysis extensions for the MIPAV software package. J Neurosci Methods 2007; 165: 111-121.
21. Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL: A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 2010; 49: 1524-1535.
22. Carass A, Cuzzocreo J, Wheeler MB, Bazin PL, Resnick SM, Prince JL: Simple paradigm for extra-cerebral tissue removal: algorithm and analysis. Neuroimage 2011; 56: 1982-1992.
23. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932-1939.
24. Uehara T, Tabuchi M, Mori E: Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke 1999; 30: 378-382.
25. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 2006; 37: 2493-2498.
26. Rosamond W, Broda G, Kawalec E, Rywik S, Pajak A, Cooper L, Chambless L: Comparison of medical care and survival of hospitalized patients with acute myocardial infarction in Poland and the United States. Am J Cardiol 1999; 83: 1180-1185.
27. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB: State of disparities in cardiovascular health in the United States. Circulation 2005; 111: 1233-1241.
28. Feinstein M, Ning H, Kang J, Bertoni A, Carnethon M, Lloyd-Jones DM: Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation 2012; 126: 50-59.
29. Hozawa A, Folsom AR, Sharrett AR, Chambless LE: Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects- Atherosclerosis Risk in Communities Study. Arch Intern Med 2007; 167: 573-579.
30. Gottesman RF, Coresh J, Catellier DJ, Sharrett AR, Rose KM, Coker LH, Shibata DK, Knopman DS, Jack CR, Mosley TH Jr: Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010; 41: 3-8.
31. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689.
32. Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G; LADIS Study Group: The spatial distribution of age-related white matter changes as a function of vascular risk factors-results from the LADIS study. Neuroimage 2012; 60: 1597-1607.
33. Enzinger C, Smith S, Fazekas F, Drevin G, Ropele S, Nichols T, Behrens T, Schmidt R, Matthews PM: Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006; 253: 1064-1070.
34. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-432.
35. Becker DM, Yook RM, Moy TF, Blumenthal RS, Becker LC: Markedly high prevalence of coronary risk factors in apparently healthy African-American and white siblings of persons with premature coronary heart disease. Am J Cardiol 1998; 82: 1046-1051.
36. Simoni M, Li L, Paul NL, Gruter BE, Schulz UG, Kuker W, Rothwell PM: Age-and sexspecific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology 2012; 79: 1215-1222.
37. Goveas JS, Espeland MA, Hogan P, Dotson V, Tarima S, Coker LH, Ockene J, Brunner R, Woods NF, Wassertheil-Smoller S, Kotchen JM, Resnick S: Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study. J Affect Disord 2011; 132: 275-284.
38. Putaala J, Haapaniemi E, Kurkinen M, Salonen O, Kaste M, Tatlisumak T: Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients. Neurology 2011; 76: 1742-1749.
39. Arsava EM, Bayrlee A, Vangel M, Rost NS, Rosand J, Furie KL, Sorensen AG, Ay H: Severity of leukoaraiosis determines clinical phenotype after brain infarction. Neurology 2011; 77: 55-61.
40. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C: Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004; 35: 1857-1861.